Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.05 par value
-
Shares outstanding
-
2K
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
12K
-
Shares change
-
+5K
-
Total reported value, excl. options
-
$436K
-
Value change
-
+$182K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$36.35
Significant Holders of SURMODICS INC - Common Stock, $0.05 par value (SRDX) as of Q4 2023
2 filings reported holding SRDX - SURMODICS INC - Common Stock, $0.05 par value as of Q4 2023.
SURMODICS INC - Common Stock, $0.05 par value (SRDX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12K shares
.
Largest 10 shareholders include Trigran Investments, Inc. (2.36M shares), MORGAN STANLEY (1.24M shares), BlackRock Inc. (1.08M shares), VANGUARD GROUP INC (859K shares), Soleus Capital Management, L.P. (772K shares), MILLENNIUM MANAGEMENT LLC (672K shares), DISCIPLINED GROWTH INVESTORS INC /MN (615K shares), RENAISSANCE TECHNOLOGIES LLC (584K shares), ROYCE & ASSOCIATES LP (420K shares), and SEGALL BRYANT & HAMILL, LLC (404K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.